Monday, Minrad International, Inc. (BUF), an interventional pain management company, announced that it has received marketing approval from the U.S. Food and Drug Administration center for veterinary medicine for Petrem, a trademark of Sevoflurane inhalation anesthetic.
Sevoflurane is used for induction and maintenance of general anesthesia.
The Orchard Park, New York-based company also stated that earlier this week, it started US product launch to the veterinary market.
BUF closed Monday's regular trading session at $1.96, down $0.02 or 1.01%.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.